Causaly raises €15.3M Series A round
20 May 2021· London, United Kingdom· health, drug_discovery, ai, knowledge_graph, b2b, pure_software
To grow its team and expand into new markets, specifically the American market, and to accelerate medical research, drug discovery, and the delivery of scientific breakthroughs.
Investors
LeadIndex Ventures
Also participating
MarathonPentechEBRD
About Causaly
Key People
Yiannis KiachopoulosCo-Founder & CEO
Artur SaudabayevCo-Founder & CTO
Stage
Series B
Headquarters
London, United Kingdom
Founded
2018
Team Size
51–200
Sectors
healthdrug_discoveryaiknowledge_graphb2bpure_software